Veraxa Biotech (VRXA) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 30 64 sessions, June 11, 2026 to September 11, 2026
- Largest daily move
- -55.5% close of June 16, 2026
Company Description
Veraxa Biotech (NASDAQ: VRXA) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $229.1M.
VRXA has declined 12.7% over the past month. The last closing price was $1.65.
This page collects what Stock Titan holds for VRXA, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Veraxa Biotech (VRXA) closed at $1.65 on September 11, 2026. Over the past month, the price has lost 12.7%.
VRXA Metrics & Rankings
Price returns through September 11, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Veraxa Biotech has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include partnership, AI. View all VRXA news →
SEC Filings
Veraxa Biotech has filed 5 recent SEC filings, including 2 Form 4, 2 Form 424B3, 1 Form 6-K. The most recent filing was submitted on September 4, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all VRXA SEC filings →
Insider Radar
Insider buying activity at Veraxa Biotech over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
VXA-102 IND/CTA readiness
Capital band expiry
Veraxa Biotech has 2 upcoming scheduled events. The next event, "VXA-102 IND/CTA readiness", is scheduled for January 1, 2028 (in 475 days). Investors can track these dates to stay informed about potential catalysts that may affect the VRXA stock price.
Short Interest History
Short interest in Veraxa Biotech (VRXA) currently stands at 378.2 thousand shares, down 5.3% from the previous reporting period, representing 0.9% of the float. Since June 2026, short interest has increased by 3616.8%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Veraxa Biotech (VRXA) currently stands at 3.6 days, up 192.7% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 249% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 3.6 days.
VRXA Company Profile & Sector Positioning
Veraxa Biotech (VRXA) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.